NCT01511367View on ClinicalTrials.gov

Comparison of Flutiform, Fluticasone and Seretide in Treatment of Moderate to Severe Asthma in Paediatric Patients

PHASE3CompletedINTERVENTIONAL

Enrollment

498

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

September 30, 2013

Study Completion Date

November 30, 2013

Conditions

Asthma

Interventions

DRUG

Flutiform

50/5ug (fluticasone/formoterol) 2 puffs twice daily

DRUG

Seretide

50/25 ug (fluticasone/salmeterol) 2 puffs twice daily

DRUG

Flixotide

50ug 2 puffs twice daily

Trial Locations (8)

Unknown

Plovdiv

Alergologie Skopkova s.r.o, Ostrava-Marianske Hory

Illés és Ádám Egészségügyi Szolgáltató Bt., Kiskunhalas

New Dehli

Alergo-Med Specjalistyczna Przychodnia Lekarska Sp.z.o.o., Tarnów

Spitalul Judetean de Urgenta Deva, Deva, Hunedoara

Moscow

Odesa

All Listed Sponsors

lead

Mundipharma Research Limited

INDUSTRY

NCT01511367 - Comparison of Flutiform, Fluticasone and Seretide in Treatment of Moderate to Severe Asthma in Paediatric Patients | Biotech Hunter | Biotech Hunter